Search Results - "Gil A"

A computational framework for detecting inter-tissue gene-expression coordination changes with aging

Shaked Briller, Gil Ben David, Yam Amir, Gil Atzmon, Judith Somekh

electronic resource

View item

A 'boring' worm? New World screwworm neuromyiasis in a patient with Darier disease

Lynna J. Yang, BA, Gil Abramovici, MD, Joaquin Brieva, MD, Amy S. Paller, MD

electronic resource

View item; View item

Immobility of isolated swarmer cells due to local liquid depletion

Ajesh Jose, Benjamín Pérez-Estay, Shira Omer Bendori, Avigdor Eldar, Daniel B. Kearns, Gil Ariel, Avraham Be’er

electronic resource

View item

Linking peri-implantitis to microbiome changes in affected implants, healthy implants, and saliva: a cross-sectional pilot study

Lucinda J. Bessa, Conceição Egas, Carolina Pires, Luís Proença, Paulo Mascarenhas, Ricardo J. Pais, Helena Barroso, Vanessa Machado, João Botelho, Gil Alcoforado, José João Mendes, Ricardo Alves

electronic resource

View item; View item

Nonhematopoietic Stem Cell Identification and Sorting in Adult Retina

Flores, Ana^Aff3, Fernández-Sánchez, Laura^Aff4, Kutsyr, Oksana^Aff4, Yáñez, Alberto^Aff3, Gil, María Luisa^Aff3, Gozalbo, Daniel^Aff3, Maneu, Victoria^Aff4, Lax, Pedro^Aff5

Ortega, Felipe^Aff2, Walker, John M.^Aff1

Diversification of molecular pattern recognition in bacterial NLR-like proteins

Nathalie Béchon, Nitzan Tal, Avigail Stokar-Avihail, Alon Savidor, Meital Kupervaser, Sarah Melamed, Gil Amitai, Rotem Sorek

electronic resource

View item

Alteration of Lipid Metabolism in Hypoxic Cancer Cells

Gil A. Gonzalez, Ezinne U. Osuji, Natalie C. Fiur, Matthew G. Clark, Seohee Ma, Laura L. Lukov, Chi Zhang

electronic resource

View item

Network Pharmacology Approaches Used to Identify Therapeutic Molecules for Chronic Venous Disease Based on Potential miRNA Biomarkers

Oscar Salvador Barrera-Vázquez, Juan Luis Escobar-Ramírez, Gil Alfonso Magos-Guerrero

electronic resource

View item; View item; View item

Citation penalties following sexual versus scientific misconduct allegations.

Giulia Maimone, Gil Appel, Craig R M McKenzie, Ayelet Gneezy

electronic resource

View item

Phenotypic Characterization of B-Lymphocyte Subpopulations in Human Peripheral Blood: A Cost-Effective Seven-Color One-Tube Protocol

Pinto, Thalyta Nery Carvalho^Aff5, Benard, Gil^Aff5, Fernandes, Juliana Ruiz^Aff5

Amoriello, Roberta^Aff2, Ballerini, Clara^Aff3, Mariottini, Alice^Aff4, Walker, John M.^Aff1

The d3GHR carrier epigenome in Druze clan longevity

Ghadeer Falah, Alina Kurolap, Tamar Paperna, Nina Ekhilevitch, Nivin Moustafa, Nadine Damouny-Naoum, Yam Amir, Lital Sharvit, Rihan Moghrabi, Gamal Hassoun, Fuad Fares, Hagit Baris Feldman, Gil Atzmon

electronic resource

View item

Neutral beam microscopy with a reciprocal space approach using magnetic beam spin encoding

Morgan Lowe, Yosef Alkoby, Helen Chadwick, Gil Alexandrowicz

electronic resource

View item

Polygenic prediction of human longevity on the supposition of pervasive pleiotropy

M. Reza Jabalameli, Jhih-Rong Lin, Quanwei Zhang, Zhen Wang, Joydeep Mitra, Nha Nguyen, Tina Gao, Mark Khusidman, Sanish Sathyan, Gil Atzmon, Sofiya Milman, Jan Vijg, Nir Barzilai, Zhengdong D. Zhang

electronic resource

View item

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma

Kuras, Magdalena, Betancourt, Lazaro Hiram, Hong, Runyu, Szadai, Leticia, Rodriguez, Jimmy, Horvatovich, Peter, Pla, Indira, Eriksson, Jonatan, Szeitz, Beáta, Deszcz, Bartłomiej, Welinder, Charlotte, Sugihara, Yutaka, Ekedahl, Henrik, Baldetorp, Bo, Ingvar, Christian, Lundgren, Lotta, Lindberg, Henrik, Oskolas, Henriett, Horvath, Zsolt, Rezeli, Melinda, Gil, Jeovanis, Appelqvist, Roger, Kemény, Lajos V, Malm, Johan, Sanchez, Aniel, Szasz, Attila Marcell, Pawłowski, Krzysztof, Wieslander, Elisabet, Fenyö, David, Nemeth, Istvan Balazs, Marko-Varga, György

Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Clinical Protein Science and Imaging, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Clinical Protein Science and Imaging, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Biomedical Engineering, Division for Biomedical Engineering, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för biomedicinsk teknik, Avdelningen för biomedicinsk teknik, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, BioMS, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, BioMS, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Lymphoma - Clinical Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Lymfom - Klinisk forskning, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Lund Melanoma Study Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Lunds Melanomstudiegrupp, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes

Pla, Indira, Szabolcs, Botond L., Péter, Petra Nikolett, Ujfaludi, Zsuzsanna, Kim, Yonghyo, Horvatovich, Peter, Sanchez, Aniel, Pawlowski, Krzysztof, Wieslander, Elisabet, Kuras, Magdalena, Murillo, Jimmy Rodriguez, Guedes, Jéssica, Pál, Dorottya M.P., Ascsillán, Anna A., Betancourt, Lazaro Hiram, Németh, István Balázs, Gil, Jeovanis, de Almeida, Natália Pinto, Szeitz, Beáta, Szadai, Leticia, Doma, Viktória, Woldmar, Nicole, Bartha, Áron, Pahi, Zoltan, Pankotai, Tibor, Győrffy, Balázs, Szasz, A. Marcell, Domont, Gilberto, Nogueira, Fábio, Kwon, Ho Jeong, Appelqvist, Roger, Kárpáti, Sarolta, Fenyö, David, Malm, Johan, Marko-Varga, György, Kemény, Lajos V.

Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Clinical Protein Science and Imaging, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Clinical Protein Science and Imaging, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Biomedical Engineering, Division for Biomedical Engineering, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för biomedicinsk teknik, Avdelningen för biomedicinsk teknik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

From theory to practice: Harmonizing taxonomies of trustworthy AI

Christos A. Makridis, Joshua Mueller, Theo Tiffany, Andrew A. Borkowski, John Zachary, Gil Alterovitz

electronic resource

View item; View item

CRISPR-Cas9 mediated d3GHR knockout in HEK293 cells: Revealing the longevity associated isoform stress resilience

Ghadeer Falah, Lital Sharvit, Gil Atzmon

electronic resource

View item; View item

The Future of Social Media in Marketing

Andrew T. Stephen, Lauren Grewal, Gil Appel, Rhonda Hadi, Şeyda Koçak Kurt

electronic resource

View item; View item

Exploring AI-Driven Machine Learning Approaches for Optimal Classification of Peri-Implantitis Based on Oral Microbiome Data: A Feasibility Study

Ricardo Jorge Pais, João Botelho, Vanessa Machado, Gil Alcoforado, José João Mendes, Ricardo Alves, Lucinda J. Bessa

electronic resource

View item; View item

From Attendance Data to Student Support: International Practices for Recording, Reporting, and Using Data on School Attendance and Absence

David Heyne, Gil Antoine Keppens, Dominik Dvořák

electronic resource

View item; View item